Assignee
IMMUTEP
FR·2 granted patents·4 pending applications·4 citations·filing 2017–2023
Top patents by PatentIndex Score
6 records- 0184US11583582B2Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune responseIMMUTEP·Filed 2019·Granted Feb 21, 2023·1 cites·11 claims
- 0282US10232038B2Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune responseIMMUTEP·Filed 2017·Granted Mar 19, 2019·3 cites·17 claims
- 0379US2024301055A1Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune diseaseIMMUTEP·Filed 2023·Application pending·0 cites
- 0478US2023149541A1Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune responseIMMUTEP·Filed 2023·Application pending·0 cites
- 0569US2021317210A1Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune diseaseIMMUTEP·Filed 2021·Application pending·0 cites
- 0666US2019135916A1Cytotoxic anti-lag-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune diseaseIMMUTEP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUTEP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →